ReviewAmerican journal of cancer research2026

PAX1/JAM3 methylation-a novel biomarker for early detection and accurate management of cervical adenocarcinoma.

Shuxian Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.